Asahi Kasei and Bluestar study mPPE production in China

Asahi Kasei and Bluestar, a ChemChina subsidiary, have agreed to study the economics of building production facilities for modified polyphenylene ether (mPPE) in China, including intermediates. A final investment decision is planned by March 2018.

“Japan’s Asahi Kasei and China’s Bluestar, a ChemChina subsidiary, have agreed to study the economics of building production facilities for producing a modified polyphenylene ether (mPPE) in China.”chemanager-online.com

• 1 source
• chemanager-online.comAsahi Kasei and Bluestar Studying mPPE • CHEManager is the market-leading medium for the management of the chemical and pharmaceutical industryOct 2, 2017

Summarized from public sources; check the original articles before acting on it.